Literature DB >> 3755633

Carcinoid syndrome. Surgical management.

R B Galland, L H Blumgart.   

Abstract

Carcinoid syndrome occurs in about five percent of patients with carcinoid tumours. Most of these patients have diffuse liver metastases at the first presentation and the surgical options are few. Medical treatment or hepatic dearterialization achieves a temporary response in most cases. Occasionally, the liver lesions are confined to one anatomical lobe and resection may be feasible.

Entities:  

Mesh:

Year:  1986        PMID: 3755633

Source DB:  PubMed          Journal:  Br J Hosp Med        ISSN: 0007-1064


  4 in total

Review 1.  Controlling the carcinoid syndrome.

Authors:  H J Hodgson
Journal:  BMJ       Date:  1988-11-12

Review 2.  Neuroendocrine metastases of the liver.

Authors:  I Ihse; B Persson; S Tibblin
Journal:  World J Surg       Date:  1995 Jan-Feb       Impact factor: 3.352

3.  Surgical treatment of neuroendocrine liver metastases.

Authors:  Ser Yee Lee; Peng Chung Cheow; Jin Yao Teo; London L P J Ooi
Journal:  Int J Hepatol       Date:  2012-01-26

4.  Comparison of survival between malignant neuroendocrine tumours of midgut and pancreatic origin.

Authors:  V Johanson; L E Tisell; L Olbe; B Wängberg; O Nilsson; H Ahlman
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.